Showing 1 - 1 results of 1 for search 'Hongqin Zhao', query time: 0.04s Refine Results
  1. 1
    A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context

    A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context by Qiang Wen, Hao Yu, Mei Pan, Hongtu Chao, Yuhua Gao, Shuhuai Niu, Hongqin Zhao, Youguo Chen, Jianqing Zhu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: